US3798209A
(en)
|
1971-06-01 |
1974-03-19 |
Icn Pharmaceuticals |
1,2,4-triazole nucleosides
|
JPS5246234B2
(pt)
|
1972-05-02 |
1977-11-22 |
|
|
GB1437800A
(en)
|
1973-08-08 |
1976-06-03 |
Phavic Sprl |
Derivatives of 2-benzamido-5-nitro-thiazoles
|
NO154918C
(no)
|
1977-08-27 |
1987-01-14 |
Bayer Ag |
Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
|
DE2758025A1
(de)
|
1977-12-24 |
1979-07-12 |
Bayer Ag |
Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung
|
JPS55111420A
(en)
|
1979-02-20 |
1980-08-28 |
Ono Pharmaceut Co Ltd |
Antitumorigenic agent
|
US4643992A
(en)
|
1982-11-09 |
1987-02-17 |
Scripps Clinic And Research Foundation |
Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
|
US4539205A
(en)
|
1982-11-09 |
1985-09-03 |
Scripps Clinic And Research Foundation |
Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
|
US5011828A
(en)
|
1985-11-15 |
1991-04-30 |
Michael Goodman |
Immunostimulating guanine derivatives, compositions and methods
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
US4880784A
(en)
|
1987-12-21 |
1989-11-14 |
Brigham Young University |
Antiviral methods utilizing ribofuranosylthiazolo[4,5-d]pyrimdine derivatives
|
US5041426A
(en)
|
1987-12-21 |
1991-08-20 |
Brigham Young University |
Immune system enhancing 3-β-d-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and nucleotides
|
HU212924B
(en)
|
1989-05-25 |
1996-12-30 |
Chiron Corp |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
JP2886570B2
(ja)
|
1989-09-29 |
1999-04-26 |
エーザイ株式会社 |
縮合ヘテロ環を有する化合物
|
JPH05320143A
(ja)
|
1992-03-18 |
1993-12-03 |
Mochida Pharmaceut Co Ltd |
新規ピリミジン誘導体
|
HUT70461A
(en)
|
1992-04-01 |
1995-10-30 |
Merck Anc Co Inc |
Recombinant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv invention
|
TW274550B
(pt)
|
1992-09-26 |
1996-04-21 |
Hoechst Ag |
|
US5395937A
(en)
|
1993-01-29 |
1995-03-07 |
Minnesota Mining And Manufacturing Company |
Process for preparing quinoline amines
|
WO1995018616A2
(en)
|
1994-01-03 |
1995-07-13 |
Acea Pharm Inc |
8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/nmda receptor
|
US5681835A
(en)
|
1994-04-25 |
1997-10-28 |
Glaxo Wellcome Inc. |
Non-steroidal ligands for the estrogen receptor
|
JPH07330770A
(ja)
|
1994-06-03 |
1995-12-19 |
Japan Energy Corp |
プリン誘導体及びそれを有効成分とする治療剤
|
JPH09169555A
(ja)
|
1995-12-19 |
1997-06-30 |
Ebata Kk |
成形用複合材料、成形物及びその製造方法
|
ZA973884B
(en)
|
1996-05-23 |
1998-11-06 |
Du Pont Merck Pharma |
Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
|
ATE283855T1
(de)
|
1996-07-03 |
2004-12-15 |
Sumitomo Pharma |
Neue purinderivate
|
SK14099A3
(en)
|
1996-08-06 |
2000-05-16 |
Pfizer |
Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
|
US5693641A
(en)
|
1996-08-16 |
1997-12-02 |
Berlex Laboratories Inc. |
Bicyclic pyrimidine derivatives and their use as anti-coagulants
|
GB9716557D0
(en)
|
1997-08-06 |
1997-10-08 |
Glaxo Group Ltd |
Benzylidene-1,3-dihydro-indol-2-one derivatives having anti-cancer activity
|
ES2205573T3
(es)
|
1997-11-28 |
2004-05-01 |
Sumitomo Pharmaceuticals Company, Limited |
Nuevo compuestos heterociclicos.
|
RU2226529C2
(ru)
|
1997-12-19 |
2004-04-10 |
Шеринг Акциенгезельшафт |
Производные ортоантраниламида в качестве антикоагулянтов, фармацевтическая композиция и способ лечения
|
TW572758B
(en)
|
1997-12-22 |
2004-01-21 |
Sumitomo Pharma |
Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives
|
JP4160645B2
(ja)
|
1997-12-24 |
2008-10-01 |
大日本住友製薬株式会社 |
新規アデニン誘導体及びその医薬用途
|
AU4719699A
(en)
|
1998-06-26 |
2000-01-17 |
Du Pont Pharmaceuticals Company |
Substituted quinoxalin-2(1h)-ones useful as hiv reverse transcriptase inhibitors
|
CZ27399A3
(cs)
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
US6629831B2
(en)
|
1999-04-16 |
2003-10-07 |
Coach Wei |
Apparatus for altering the physical properties of fluids
|
JP2001012367A
(ja)
|
1999-06-28 |
2001-01-16 |
Sanden Corp |
スクロール型圧縮機
|
CZ2002846A3
(cs)
|
1999-09-15 |
2003-02-12 |
Warner-Lambert Company |
Pteridinony, jako inhibitory kinasy
|
US6452325B1
(en)
|
2000-07-24 |
2002-09-17 |
Thermoplastic Processes, Inc. |
Shatterproofing of fluorescent lamps
|
US6664260B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Heterocyclic ether substituted imidazoquinolines
|
US6545017B1
(en)
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Urea substituted imidazopyridines
|
US6667312B2
(en)
|
2000-12-08 |
2003-12-23 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
US6545016B1
(en)
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Amide substituted imidazopyridines
|
US6664264B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
CA2435568A1
(en)
|
2001-01-26 |
2002-08-01 |
The Immune Response Corporation |
Method for treating an hiv-infected individual by combining immunization with structured interruption of anti-retroviral treatment
|
WO2002076954A1
(en)
|
2001-03-23 |
2002-10-03 |
Smithkline Beecham Corporation |
Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
|
JP4331944B2
(ja)
|
2001-04-17 |
2009-09-16 |
大日本住友製薬株式会社 |
新規アデニン誘導体
|
JP3876254B2
(ja)
|
2001-09-04 |
2007-01-31 |
ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト |
新規なジヒドロプテリジノン、その製造方法及びその医薬組成物としての使用
|
US6806272B2
(en)
|
2001-09-04 |
2004-10-19 |
Boehringer Ingelheim Pharma Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
NZ539064A
(en)
|
2002-09-27 |
2007-09-28 |
Dainippon Sumitomo Pharma Co |
Novel adenine compound and use thereof
|
US6960568B2
(en)
|
2002-12-17 |
2005-11-01 |
Yale University |
Nucleosides and related processes, pharmaceutical compositions and methods
|
DE50307267D1
(de)
|
2003-02-26 |
2007-06-21 |
Boehringer Ingelheim Pharma |
Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
|
WO2005016348A1
(en)
|
2003-08-14 |
2005-02-24 |
Icos Corporation |
Method of inhibiting immune responses stimulated by an endogenous factor
|
WO2005016349A1
(en)
|
2003-08-14 |
2005-02-24 |
Icos Corporation |
Methods of inhibiting leukocyte accumulation
|
OA13310A
(en)
|
2003-09-05 |
2007-04-13 |
Anadys Pharmaceuticals Inc |
TLR7 ligands for the treatment of hepatitis C.
|
JP2005089334A
(ja)
|
2003-09-12 |
2005-04-07 |
Sumitomo Pharmaceut Co Ltd |
8−ヒドロキシアデニン化合物
|
WO2005067901A2
(en)
|
2004-01-08 |
2005-07-28 |
Michigan State University |
Methods for treating and preventing hypertension and hypertension-related disorders
|
US7592326B2
(en)
|
2004-03-15 |
2009-09-22 |
Karaolis David K R |
Method for stimulating the immune, inflammatory or neuroprotective response
|
MXPA06011080A
(es)
|
2004-03-26 |
2007-04-16 |
Astrazeneca Ab |
Compuesto de 8-oxoadenina 9-sustituido.
|
CA2730540A1
(en)
|
2004-05-13 |
2005-12-01 |
Vanderbilt University |
Phosphoinositide 3-kinase delta selective inhibitors for inhibiting angiogenesis
|
EP1755609A1
(en)
|
2004-05-25 |
2007-02-28 |
Icos Corporation |
Methods for treating and/or preventing aberrant proliferation of hematopoietic cells
|
JP2008500984A
(ja)
|
2004-05-28 |
2008-01-17 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
ヴィロソームとサポニンアジュバントを含むワクチン組成物
|
CN101123968A
(zh)
|
2004-06-04 |
2008-02-13 |
艾科斯有限公司 |
肥大细胞病的治疗方法
|
DE102004029784A1
(de)
|
2004-06-21 |
2006-01-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
|
US20060058286A1
(en)
|
2004-09-16 |
2006-03-16 |
Mark Krystal |
Methods of treating HIV infection
|
EP1885356A2
(en)
|
2005-02-17 |
2008-02-13 |
Icos Corporation |
Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
|
US7498409B2
(en)
|
2005-03-24 |
2009-03-03 |
Schering Corporation |
Screening assay for TLR7, TLR8 and TLR9 agonists and antagonists
|
DK1869037T3
(da)
|
2005-03-25 |
2011-10-24 |
Tibotec Pharm Ltd |
Heterobicykliske inhibitorer af HVC
|
CA2607780A1
(en)
|
2005-05-04 |
2006-11-09 |
Pfizer Limited |
Purine derivatives
|
SE531106C2
(sv)
|
2005-05-26 |
2008-12-16 |
Pemtec Ab |
Tätningsorgan
|
CA2617589A1
(en)
|
2005-08-03 |
2007-02-08 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinones in the treatment of respiratory diseases
|
ES2577514T3
(es)
|
2005-08-22 |
2016-07-15 |
The Regents Of The University Of California |
Antagonistas de TLR
|
KR20080031496A
(ko)
|
2005-09-02 |
2008-04-08 |
화이자 인코포레이티드 |
히드록시 치환된 1h-이미다조피리딘 및 방법
|
TW200801003A
(en)
|
2005-09-16 |
2008-01-01 |
Astrazeneca Ab |
Novel compounds
|
US20090192153A1
(en)
|
2005-09-22 |
2009-07-30 |
Dainippon Sumitomo Pharma Co., Ltd. a corporation of Japan |
Novel adenine compound
|
EP1939199A4
(en)
|
2005-09-22 |
2010-10-20 |
Dainippon Sumitomo Pharma Co |
NEW ADENINE CONNECTION
|
WO2007034917A1
(ja)
|
2005-09-22 |
2007-03-29 |
Dainippon Sumitomo Pharma Co., Ltd. |
新規なアデニン化合物
|
TW200745114A
(en)
|
2005-09-22 |
2007-12-16 |
Astrazeneca Ab |
Novel compounds
|
EP1939200A4
(en)
|
2005-09-22 |
2010-06-16 |
Dainippon Sumitomo Pharma Co |
NEW ADENINE CONNECTION
|
WO2007034817A1
(ja)
|
2005-09-22 |
2007-03-29 |
Dainippon Sumitomo Pharma Co., Ltd. |
新規アデニン化合物
|
JP5251127B2
(ja)
|
2005-10-28 |
2013-07-31 |
小野薬品工業株式会社 |
塩基性基を含有する化合物およびその用途
|
KR20080083270A
(ko)
|
2005-11-04 |
2008-09-17 |
콜레이 파마시티컬 그룹, 인코포레이티드 |
하이드록시 및 알콕시 치환된 1에이치 이미다조퀴놀린 및방법
|
EP1969367B1
(en)
|
2005-12-12 |
2011-08-10 |
Elan Pharmaceuticals Inc. |
Assay for parkinson's disease therapeutics
|
ES2395386T3
(es)
|
2005-12-21 |
2013-02-12 |
Abbott Laboratories |
Compuestos antivirales
|
ATE479434T1
(de)
|
2006-02-14 |
2010-09-15 |
Vertex Pharma |
Als protein-kinase-inhibitoren nutzbare dyhydrodiazepine
|
AU2007216247A1
(en)
|
2006-02-17 |
2007-08-23 |
Pfizer Limited |
3 -deazapurine derivatives as TLR7 modulators
|
AU2007223801A1
(en)
|
2006-03-08 |
2007-09-13 |
Amgen Inc. |
Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
|
CA2644716A1
(en)
|
2006-03-13 |
2007-09-27 |
Merck & Co., Inc. |
Ophthalmic compositions for treating ocular hypertension
|
US8088788B2
(en)
|
2006-03-15 |
2012-01-03 |
3M Innovative Properties Company |
Substituted fused[1,2] imidazo[4,5-c] ring compounds and methods
|
EP2700638A1
(en)
|
2006-05-31 |
2014-02-26 |
The Regents Of the University of California |
Purine analogs
|
WO2007148064A1
(en)
|
2006-06-23 |
2007-12-27 |
Astrazeneca Ab |
Pteridine derivatives and their use as cathespin inhibitors
|
JP2009542645A
(ja)
|
2006-07-05 |
2009-12-03 |
アストラゼネカ・アクチエボラーグ |
Tlr7のモジュレーターとして作用する8−オキソアデニン誘導体
|
ES2437871T3
(es)
|
2006-07-07 |
2014-01-14 |
Gilead Sciences, Inc. |
Moduladores del receptor tipo toll 7
|
US7866135B2
(en)
|
2006-08-28 |
2011-01-11 |
Exmark Manufacturing Company, Inc. |
Flow control baffle for turf mower
|
EP2457913B1
(en)
|
2006-10-19 |
2017-04-19 |
Signal Pharmaceuticals, LLC |
Heteroaryl compounds, compositions thereof, and methods of treatment therewith
|
JP2010508371A
(ja)
|
2006-11-06 |
2010-03-18 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
グルコピラノシル置換フェニル誘導体、該化合物を含有する医薬品及びその使用と製造方法
|
TW200831105A
(en)
|
2006-12-14 |
2008-08-01 |
Astrazeneca Ab |
Novel compounds
|
CL2008000496A1
(es)
|
2007-02-19 |
2008-09-22 |
Smithkline Beecham Corp |
Compuestos derivados de purina; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar enfermedades infecciosas, cancer, alergias y otras afecciones inflamatorias.
|
NZ579802A
(en)
|
2007-02-23 |
2012-04-27 |
Gilead Sciences Inc |
Compounds for improving the efficacy of other drugs
|
WO2008114006A1
(en)
|
2007-03-19 |
2008-09-25 |
Astrazeneca Ab |
9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7) modulators
|
US8067413B2
(en)
|
2007-03-19 |
2011-11-29 |
Astrazeneca Ab |
9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7 ) modulators
|
EP2138497A4
(en)
|
2007-03-20 |
2012-01-04 |
Dainippon Sumitomo Pharma Co |
NEW ADENINE CONNECTION
|
TW200902018A
(en)
|
2007-03-20 |
2009-01-16 |
Dainippon Sumitomo Pharma Co |
Novel adenine compound
|
CN101636399B
(zh)
|
2007-03-22 |
2012-04-18 |
武田药品工业株式会社 |
可用作plk1抑制剂的取代的嘧啶并二氮杂*
|
US20100179109A1
(en)
|
2007-04-05 |
2010-07-15 |
Baldwin Jonh J |
Renin inhibitors
|
CA2683434A1
(en)
|
2007-04-05 |
2008-10-16 |
Siemens Medical Solutions Usa, Inc. |
Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry
|
EP2143724B1
(en)
|
2007-04-18 |
2013-12-11 |
Kissei Pharmaceutical Co., Ltd. |
Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
|
MY150519A
(en)
|
2007-05-08 |
2014-01-30 |
Astrazeneca Ab |
Imidazoquinolines with immuno-modulating properties
|
JP5824212B2
(ja)
|
2007-05-15 |
2015-11-25 |
ストライカー コーポレイションStryker Corporation |
骨形成タンパク質の濃縮されたタンパク質製剤およびその使用方法
|
JP2009007273A
(ja)
|
2007-06-27 |
2009-01-15 |
Ajinomoto Co Inc |
ジアミノピリミジン化合物の製造方法
|
CA2691444C
(en)
|
2007-06-29 |
2016-06-14 |
Gilead Sciences, Inc. |
Purine derivatives and their use as modulators of toll-like receptor 7
|
DE602008005470D1
(en)
|
2007-08-03 |
2011-04-21 |
Pfizer Ltd |
Imidazopyridinone
|
JP5380447B2
(ja)
|
2007-08-15 |
2014-01-08 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
増殖性疾患の処置のための、ヒトタンパク質キナーゼplk1ないしplk4の阻害剤としての4−(9−(3,3−ジフルオロシクロペンチル)−5,7,7−トリメチル−6−オキソ−6,7,8,9−テトラヒドロ−5h−ピリミド[4,5−b[1,4]ジアゼパン−2−イルアミノ]−3−メトキシベンザミド誘導体
|
WO2009022185A2
(en)
|
2007-08-16 |
2009-02-19 |
Astrazeneca Ab |
6, 6-fused heterocycles, their pharmaceutical compositions and methos of use
|
MX2010005334A
(es)
|
2007-11-16 |
2010-05-27 |
Boehringer Ingelheim Int |
Inhibidores de la replicacion del virus de la inmunodeficiencia humana.
|
WO2009067547A1
(en)
|
2007-11-19 |
2009-05-28 |
Takeda Pharmaceutical Company Limited |
Polo-like kinase inhibitors
|
PE20091236A1
(es)
|
2007-11-22 |
2009-09-16 |
Astrazeneca Ab |
Derivados de pirimidina como immunomoduladores de tlr7
|
EP2268642B1
(en)
|
2008-04-23 |
2015-02-25 |
Gilead Sciences, Inc. |
1' -substituted carba-nucleoside analogs for antiviral treatment
|
WO2009151910A2
(en)
|
2008-05-25 |
2009-12-17 |
Wyeth |
Combination product of receptor tyrosine kinase inhibitor and fatty acid synthase inhibitor for treating cancer
|
CN101284810A
(zh)
|
2008-06-02 |
2008-10-15 |
秦引林 |
氰基吡咯烷和氰基噻唑烷衍生物
|
WO2009155332A1
(en)
|
2008-06-17 |
2009-12-23 |
Cedars-Sinai Medical Center |
Use of toll-like receptor ligands as adjuvants to vaccination therapy for brain tumors
|
PT2313111E
(pt)
|
2008-08-01 |
2013-12-05 |
Ventirx Pharmaceuticals Inc |
Formulações de agonista de receptor do tipo toll e seus usos
|
ES2433371T3
(es)
|
2008-08-11 |
2013-12-10 |
Glaxosmithkline Llc |
Derivados de purina para uso en el tratamiento de enfermedades alérgicas, inflamatorias e infecciosas
|
UA103195C2
(uk)
|
2008-08-11 |
2013-09-25 |
Глаксосмитклайн Ллк |
Похідні пурину для застосування у лікуванні алергій, запальних та інфекційних захворювань
|
LT2320905T
(lt)
|
2008-08-11 |
2017-09-11 |
Glaxosmithkline Llc |
Naujieji adenino dariniai
|
KR20110042116A
(ko)
|
2008-08-11 |
2011-04-22 |
글락소스미스클라인 엘엘씨 |
알레르기성, 염증성 및 감염성 질환의 치료에서 사용하기 위한 푸린 유도체
|
WO2010018132A1
(en)
|
2008-08-11 |
2010-02-18 |
Smithkline Beecham Corporation |
Compounds
|
US8802684B2
(en)
|
2008-08-11 |
2014-08-12 |
Glaxosmithkline Llc |
Adenine derivatives
|
DK2341933T3
(da)
|
2008-10-24 |
2018-01-29 |
Glaxosmithkline Biologicals Sa |
Lipiderede imidazoquinolinderivater.
|
AR074506A1
(es)
|
2008-12-09 |
2011-01-19 |
Gilead Sciences Inc |
Moduladores de los receptores tipo toll
|
US8202974B2
(en)
|
2009-02-10 |
2012-06-19 |
Idera Pharmaceuticals, Inc. |
Synthetic RNA-based agonists of TLR7
|
US8729088B2
(en)
|
2009-02-11 |
2014-05-20 |
The Regents Of The University Of California |
Toll-like receptor modulators and treatment of diseases
|
SI3260136T1
(sl)
|
2009-03-17 |
2021-05-31 |
Theraclone Sciences, Inc. |
Humani imunodeficientni virus (HIV)-nevtralizirajoča protitelesa
|
US8338441B2
(en)
|
2009-05-15 |
2012-12-25 |
Gilead Sciences, Inc. |
Inhibitors of human immunodeficiency virus replication
|
TWI598358B
(zh)
|
2009-05-20 |
2017-09-11 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
GB0908772D0
(en)
|
2009-05-21 |
2009-07-01 |
Astrazeneca Ab |
New salts 756
|
RU2016108987A
(ru)
|
2009-08-18 |
2018-11-26 |
Вентиркс Фармасьютикалз, Инк. |
Замещенные бензоазепины в качестве модуляторов toll-подобного рецептора
|
TWI445708B
(zh)
|
2009-09-02 |
2014-07-21 |
Irm Llc |
作為tlr活性調節劑之化合物及組合物
|
NO2477987T3
(pt)
|
2009-09-14 |
2018-06-09 |
|
|
EP2480572B1
(en)
|
2009-09-25 |
2019-01-30 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Neutralizing antibodies to hiv-1 and their use
|
PT2491035T
(pt)
|
2009-10-22 |
2017-10-30 |
Gilead Sciences Inc |
Derivados de purina ou deazapurina úteis para o tratamento de (entre outros) infeções virais
|
US9296758B2
(en)
|
2010-07-02 |
2016-03-29 |
Gilead Sciences, Inc. |
2-quinolinyl-acetic acid derivatives as HIV antiviral compounds
|
JP5984218B2
(ja)
|
2010-07-02 |
2016-09-06 |
ギリアード サイエンシーズ, インコーポレイテッド |
Aidsを処置するためのナフト−2−イル酢酸誘導体
|
PT3556396T
(pt)
|
2010-08-31 |
2022-07-04 |
Scripps Research Inst |
Anticorpos neutralizantes do vírus da imunodeficiência humana (vih)
|
UY33775A
(es)
|
2010-12-10 |
2012-07-31 |
Gilead Sciences Inc |
Inhibidores macrocíclicos de virus flaviviridae, composiciones farmacéuticas que los comprenden y sus usos
|
EP2654900A1
(en)
|
2010-12-20 |
2013-10-30 |
Gilead Sciences, Inc. |
Combinations for treating hcv
|
US9006229B2
(en)
|
2011-04-21 |
2015-04-14 |
Gilead Sciences, Inc. |
Benzothiazole compounds and their pharmaceutical use
|
CN103945864A
(zh)
|
2011-04-25 |
2014-07-23 |
先进生物学实验室股份有限公司 |
截短的hiv包膜蛋白(env)、其相关方法和组合物
|
US8728486B2
(en)
|
2011-05-18 |
2014-05-20 |
University Of Kansas |
Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds
|
TW201310216A
(zh)
|
2011-08-17 |
2013-03-01 |
Hon Hai Prec Ind Co Ltd |
電源系統
|
LT2709613T
(lt)
|
2011-09-16 |
2018-02-12 |
Gilead Pharmasset Llc |
Žmogaus hepatito viruso (hcv) gydymo būdai
|
US20130109647A1
(en)
|
2011-10-31 |
2013-05-02 |
Gilead Pharmasset Llc |
Methods and compositions for treating hepatitis c virus
|
PL2776439T3
(pl)
|
2011-11-09 |
2018-12-31 |
Janssen Sciences Ireland Uc |
Pochodne puryny do leczenia zakażeń wirusowych
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
EP2620446A1
(en)
|
2012-01-27 |
2013-07-31 |
Laboratorios Del Dr. Esteve, S.A. |
Immunogens for HIV vaccination
|
US20150105350A1
(en)
|
2012-02-03 |
2015-04-16 |
Gilead Sciences, Inc. |
Combination therapy comprising tenofovir alafenamide hemifumarate and cobicistat for use in the treatment of viral infections
|
US9375471B2
(en)
|
2012-03-08 |
2016-06-28 |
Glaxosmithkline Biologicals Sa |
Adjuvanted formulations of booster vaccines
|
EP3070081B1
(en)
|
2012-04-20 |
2018-02-28 |
Gilead Sciences, Inc. |
Benzothiazol-6-yl acetic acid derivatives and their use for treating an hiv infection
|
JP2015532277A
(ja)
|
2012-09-29 |
2015-11-09 |
ノバルティス アーゲー |
環状ペプチドおよび医薬としてのその使用
|
DK2908912T3
(da)
|
2012-10-18 |
2020-10-26 |
Univ Rockefeller |
Bredt neutraliserende anti-hiv-antistoffer
|
WO2014074952A1
(en)
|
2012-11-09 |
2014-05-15 |
Massachusetts Institute Of Technology |
Methods and compositions for localized delivery of agents to hiv-infected cells and tissues
|
EP3052132B1
(en)
|
2013-09-30 |
2020-07-29 |
Beth Israel Deaconess Medical Center, Inc. |
Antibody therapies for human immunodeficiency virus (hiv)
|
ES2930667T3
(es)
|
2014-07-11 |
2022-12-21 |
Gilead Sciences Inc |
Moduladores de receptores de tipo Toll para el tratamiento de VIH
|
MX2017003284A
(es)
|
2014-09-16 |
2017-06-28 |
Gilead Sciences Inc |
Formas solidas de modulador de receptor tipo toll.
|
ES2706527T3
(es)
|
2014-09-16 |
2019-03-29 |
Gilead Sciences Inc |
Métodos para preparar moduladores de receptores tipo Toll
|
JP2022535337A
(ja)
|
2019-05-22 |
2022-08-08 |
ギリアード サイエンシーズ, インコーポレイテッド |
Tlr7調節化合物とhivワクチンとの併用
|